NCT02951767 A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1) Status COMPLETED Phase PHASE2
NCT02951078 A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer Status UNKNOWN Phase PHASE3
NCT02948543 Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer Status UNKNOWN Phase PHASE3
NCT02942121 Application-based Perioperative Management of the Radical Cystectomy Patient Status COMPLETED Phase NA
NCT02925533 Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract Status TERMINATED Phase PHASE1
NCT02903914 Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT02901548 Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder Status TERMINATED Phase PHASE2
NCT02897375 Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02887248 Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma Status TERMINATED Phase PHASE2
NCT02886897 A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT02886026 Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors Status UNKNOWN Phase NA
NCT02885974 Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer Status COMPLETED Phase PHASE1
NCT02869217 Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02861196 Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer Status COMPLETED Phase NA
NCT02852564 Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection Status COMPLETED Phase PHASE1
NCT02852252 Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry Status COMPLETED Phase N/A
NCT02846467 Information Improvement for Surgical Patients Through Portable Video Media Status COMPLETED Phase NA
NCT02845323 Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder Status ACTIVE_NOT_RECRUITING Phase PHASE2